NCT05868967 - A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

May 31, 2023

Study Completion Date

October 31, 2023

Conditions

Phase 1 Study, Healthy Volunteers

Interventions

DRUG

[14C]DWP14012

Each subject will receive a single oral dose of \[14C\]DWP14012 suspension (containing approximately 40 mg/80 μCi \[14C\]DWP14012) under fasting conditions.

Trial Locations (1)

Unknown

Beijing GoBroad Boren Hospital, Beijing